Compton Capital Management Has Upped Amgen (AMGN) Holding by $460,350 as Stock Price Declined; As Anheuser Busch Inbev Sa/Nv (BUD) Share Value Rose, Shareholder Emerging Sovereign Group Has Decreased Position by $15.97 Million

January 17, 2018 - By Ellis Scott

Compton Capital Management Inc increased its stake in Amgen Inc (AMGN) by 39.52% based on its latest 2017Q3 regulatory filing with the SEC. Compton Capital Management Inc bought 2,475 shares as the company’s stock declined 9.68% while stock markets rallied. The institutional investor held 8,738 shares of the biological products (no diagnostic substances) company at the end of 2017Q3, valued at $1.63M, up from 6,263 at the end of the previous reported quarter. Compton Capital Management Inc who had been investing in Amgen Inc for a number of months, seems to be bullish on the $136.01B market cap company. The stock increased 0.99% or $1.83 during the last trading session, reaching $187.37. About 1.28 million shares traded. Amgen Inc. (NASDAQ:AMGN) has risen 5.27% since January 17, 2017 and is uptrending. It has underperformed by 11.43% the S&P500.

J Kevin Kenny Jr decreased its stake in Anheuser Busch Inbev Sa/Nv (BUD) by 31.14% based on its latest 2017Q3 regulatory filing with the SEC. Emerging Sovereign Group Llc sold 134,170 shares as the company’s stock rose 8.45% with the market. The hedge fund run by J Kevin Kenny Jr held 296,687 shares of the beverages (production and distribution) company at the end of 2017Q3, valued at $35.40M, down from 430,857 at the end of the previous reported quarter. Emerging Sovereign Group Llc who had been investing in Anheuser Busch Inbev Sa/Nv for a number of months, seems to be less bullish one the $221.98B market cap company. The stock increased 0.49% or $0.56 during the last trading session, reaching $116.1. About 1.11M shares traded. Anheuser-Busch InBev SA/NV (NYSE:BUD) has declined 3.55% since January 17, 2017 and is downtrending. It has underperformed by 20.25% the S&P500.

Investors sentiment decreased to 0.99 in Q3 2017. Its down 0.16, from 1.15 in 2017Q2. It dropped, as 58 investors sold AMGN shares while 511 reduced holdings. 108 funds opened positions while 453 raised stakes. 555.05 million shares or 0.41% less from 557.32 million shares in 2017Q2 were reported. 8,005 were accumulated by Invest. Hartline Inv Corp holds 10,562 shares. Pinnacle Finance accumulated 36,464 shares. Mercer Advisers owns 5,183 shares for 0.72% of their portfolio. Andra Ap owns 39,400 shares for 0.17% of their portfolio. Altfest L J Incorporated stated it has 13,057 shares. Moreover, North Amer Management has 0.06% invested in Amgen Inc. (NASDAQ:AMGN) for 2,059 shares. State Board Of Administration Of Florida Retirement holds 0.54% in Amgen Inc. (NASDAQ:AMGN) or 1.07M shares. 2,232 are held by Bsw Wealth. Duncker Streett & Incorporated reported 5,584 shares or 0.32% of all its holdings. Amica Mutual Ins owns 42,279 shares. Fishman Jay A Mi has invested 2.49% in Amgen Inc. (NASDAQ:AMGN). 31,734 were reported by Oakwood Cap Mngmt Ca. Boston Rech Inc invested in 0.11% or 1,180 shares. Kentucky Retirement Sys, a Kentucky-based fund reported 45,185 shares.

Since October 9, 2017, it had 0 insider purchases, and 2 sales for $553,240 activity.

Among 24 analysts covering Amgen Inc. (NASDAQ:AMGN), 11 have Buy rating, 0 Sell and 13 Hold. Therefore 46% are positive. Amgen Inc. had 74 analyst reports since August 3, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Wednesday, June 7 by Bernstein. The stock of Amgen Inc. (NASDAQ:AMGN) has “Buy” rating given on Friday, July 28 by Oppenheimer. The firm earned “Buy” rating on Tuesday, June 13 by Oppenheimer. As per Friday, October 13, the company rating was maintained by Barclays Capital. The stock of Amgen Inc. (NASDAQ:AMGN) has “Buy” rating given on Thursday, July 27 by Argus Research. The firm has “Outperform” rating given on Friday, July 31 by RBC Capital Markets. The stock of Amgen Inc. (NASDAQ:AMGN) has “Hold” rating given on Wednesday, April 5 by Jefferies. Oppenheimer maintained Amgen Inc. (NASDAQ:AMGN) on Friday, July 21 with “Buy” rating. On Sunday, August 27 the stock rating was maintained by Jefferies with “Buy”. The firm has “Neutral” rating by Credit Suisse given on Tuesday, December 20.

Compton Capital Management Inc, which manages about $284.24M and $222.79M US Long portfolio, decreased its stake in Jp Morgan Chase & Co (NYSE:JPM) by 8,033 shares to 79,840 shares, valued at $7.63M in 2017Q3, according to the filing.

Among 22 analysts covering Anheuser-Busch InBev (NYSE:BUD), 14 have Buy rating, 2 Sell and 6 Hold. Therefore 64% are positive. Anheuser-Busch InBev had 43 analyst reports since July 21, 2015 according to SRatingsIntel. On Thursday, October 20 the stock rating was downgraded by Societe Generale to “Hold”. Sterne Agee CRT maintained Anheuser-Busch InBev SA/NV (NYSE:BUD) on Thursday, September 17 with “Buy” rating. The firm has “Underperform” rating by RBC Capital Markets given on Wednesday, July 6. As per Friday, July 28, the company rating was maintained by Jefferies. Jefferies maintained Anheuser-Busch InBev SA/NV (NYSE:BUD) on Thursday, January 11 with “Buy” rating. The firm has “Outperform” rating given on Monday, November 16 by BNP Paribas. As per Tuesday, July 21, the company rating was initiated by Sterne Agee CRT. The firm earned “Hold” rating on Thursday, July 27 by Susquehanna. The firm has “Buy” rating given on Monday, October 3 by Liberum Capital. On Tuesday, April 5 the stock rating was downgraded by Societe Generale to “Buy”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts